CP

Caligan Partners Portfolio holdings

AUM $515M
1-Year Est. Return 70.09%
This Quarter Est. Return
1 Year Est. Return
+70.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
+$84.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$18.1M
2
+$16.4M
3
+$5.13M
4
ABVX
Abivax
ABVX
+$3.23M
5
YMAB
Y-mAbs Therapeutics
YMAB
+$2.55M

Top Sells

1
+$1.06M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$1.96B
$120M 24.99%
8,118,592
VRNA
2
DELISTED
Verona Pharma
VRNA
$91.2M 19.04%
1,436,878
EXEL icon
3
Exelixis
EXEL
$9.44B
$56.3M 11.75%
1,525,730
MLYS icon
4
Mineralys Therapeutics
MLYS
$3.36B
$34.1M 7.12%
2,149,667
+1,138,512
EOLS icon
5
Evolus
EOLS
$419M
$32.9M 6.86%
2,731,154
+38,766
SAGE
6
DELISTED
Sage Therapeutics
SAGE
$24.3M 5.06%
3,052,538
BCRX icon
7
BioCryst Pharmaceuticals
BCRX
$1.4B
$23.3M 4.86%
3,107,669
+111,737
ANIK icon
8
Anika Therapeutics
ANIK
$133M
$21.6M 4.5%
1,435,130
AGIO icon
9
Agios Pharmaceuticals
AGIO
$2.5B
$20.5M 4.29%
701,280
+75,000
RVMD icon
10
Revolution Medicines
RVMD
$10.2B
$16.4M 3.43%
+465,000
MRUS icon
11
Merus
MRUS
$7.18B
$15.9M 3.31%
376,954
+121,954
YMAB
12
DELISTED
Y-mAbs Therapeutics
YMAB
$10.4M 2.17%
2,342,609
+574,627
ABVX
13
Abivax
ABVX
$7.32B
$7.93M 1.66%
1,269,119
+516,952
VRCA icon
14
Verrica Pharmaceuticals
VRCA
$39.4M
$3.98M 0.83%
899,295
+156,326
RZLT icon
15
Rezolute
RZLT
$805M
$410K 0.09%
+141,309
TYRA icon
16
Tyra Biosciences
TYRA
$777M
$233K 0.05%
+25,000
ENTA icon
17
Enanta Pharmaceuticals
ENTA
$328M
– –
-184,826